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Abstract: The aim of this study was the determination and comparative evaluation of the seroprevalence of Brucella canis infection
in dog sera obtained from different dog shelters located in ‹stanbul and ‹zmir provinces by tube agglutination test (TAT), 2mercapto-ethanol tube agglutination test (2ME-TAT) and ELISA.
A total of 362 serum samples were obtained from 8 different dog shelters in ‹stanbul and ‹zmir provinces. The dogs were
temporarily kept in these shelters. Of the 362 serum samples, 46 (12.7%), 28 (7.73%) and 27 (7.45%) were found to be positive
by TAT, 2ME-TAT and ELISA, respectively. Dogs in 6 (75%) out of the 8 kennels were found to be positive for B. canis. The
prevalence of seropositive animals were ranged between 5.26% and 31.57%, 5% and 17.54%, and 2.12 % and 15.78% by TAT,
2ME-TAT and ELISA tests, respectively. Amongst the 46 sera evaluated as positive by TAT, 18 (39.1%) and 19 (41.3%) were found
to be negative by 2ME-TAT and ELISA tests, respectively. A 96.42% similarity was found between 2 ME-TAT and ELISA results. In
conclusion, the tube agglutination test when used together with additional tests such as 2ME-TAT and ELISA would be useful in
eliminating the false-positive results obtained in serological diagnosis of B. canis infection of dogs. Similar results were observed
between 2ME-TAT and ELISA tests. Because B. canis antibodies were detected in sera of dogs from most of the shelters examined,
it is concluded that preventive measures should be taken to eliminate B. canis from the entire dog population and carrier dogs should
be kept separated from uninfected animals. The carrier dogs may also constitute a risk for human health.
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Türkiye’nin ‹ki ‹lindeki Köpeklerde Brucella canis ‹nfeksiyonunun Seroprevalans›
Özet: Bu çal›flmada, farkl› köpek toplama ünitelerinden toplanan serum örneklerinde Brucella canis infeksiyonunun seroprevalans›n›n
tüp aglütinasyon testi (TAT), 2-mercapto-ethanol–TAT (2ME-TAT) ve ELISA testi ile belirlenmesi ve sonuçlar›n karfl›laflt›r›lmal› olarak
de¤erlendirilmesi amaçlanm›flt›r.
Çal›flmada, ‹stanbul ve ‹zmir yöresinde, farkl› yerlerden toplanan köpeklerin geçici olarak bar›nd›klar›, 8 farkl› köpek toplama
ünitesinden toplanan, toplam 362 adet serum örne¤i kullan›ld›. ‹ncelenen 362 serum örne¤inin 46 (% 12,7)’s› TAT, 28 (% 7,73)’si
2ME-TAT ve 27 (% 7,45)’si ELISA ile pozitif bulundu. Serumlar›n elde edildi¤i 8 toplama ünitesinden 6 (% 75)’s›nda B. canis
seropozitifli¤i saptand›. B. canis antikorlar› saptanan toplama ünitelerinde, seroprevalans›n TAT ile % 5,26 ile % 31,57; 2ME-TAT
ile % 5 ile % 17,54 ve ELISA testinde % 2,12 ile % 15,78 aras›nda de¤iflti¤i saptand›. TAT ile pozitif de¤erlendirilen 46 serumun
18 (% 39,1)’i 2ME-TAT ve 19 (% 41,3)’u ELISA ile negatif bulundu. ME-TAT ile ELISA bulgular› ise % 96,42 oran›nda uyumlu
bulundu.
Sonuç olarak, köpeklerde B. canis infeksiyonlar›n›n serolojik teflhisinde kullan›lan tüp aglütinasyon testinin, 2ME-TAT ve ELISA gibi
ilave bir teflhis yöntemiyle desteklenmesinin yanl›fl pozitifli¤in ortadan kald›r›lmas›nda yarar sa¤layaca¤› ve 2ME-TAT ile ELISA
bulgular›n›n birbirleri ile uyumlu oldu¤u ortaya kondu. Ayr›ca, B. canis antikorlar›n›n incelenen toplama ünitelerinin ço¤unda
saptanmas›, köpeklerde B. canis infeksiyonlar›na karfl› koruma önlemlerinin al›nmas› gereklili¤ini ve bu infeksiyonun insan sa¤l›¤› için
potansiyel bir tehlike olmaya devam etti¤ini gösterdi.
Anahtar Sözcükler: Brucella canis, köpek, prevalans, seroloji
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Introduction

Brucella canis causes canine brucellosis characterized
by abortions in females and testicular atrophy,
epididymitis and infertility in males and generalized
lymphadenitis in both sexes. It is usually a clinically
inapparent disease and many infected dogs may go
unnoticed. Carmichael identified Brucella canis in 1966 as
the cause of abortion among beagle dogs in the USA, and
several countries have reported infection since then.
Several researchers reported rates of seroprevalence
ranging between 2% and 30% in stray dogs in various
countries (1-5). Researchers have reported serological
diagnosis of infection in Turkey (6,7), but there are
insufficient data on the current status of infection.
Definitive diagnosis requires laboratory confirmation
as clinical findings such as abortion in females and
infertility in males are not specific to the disease.
Diagnosis of B. canis infection in dogs depends on both
bacteriological examination and serological methods.
Commonly used serological methods are rapid slide
agglutination test, 2-mercaptoethanol slide agglutination
test, tube agglutination test and ELISA. Following the
development of serological methods, the diagnosis of
infection has become available in routine diagnostic
laboratories (8-12). However, amongst these tests the
ones using agglutination methods have lower specificities,
and false-positive reactions are not uncommon with
them. In order to eliminate this problem, researchers
have developed ELISA techniques using purified antigens
and/or monoclonal antibodies (13,14). The exact
diagnosis of the disease requires isolation of the causative
agent. Repeated blood cultures and serologic monitoring
are required before a dog can be declared negative
(2,11).
In this study, we aimed to investigate seroprevalence
of Brucella canis infection with serum samples obtained
from different dog shelters in two provinces in Turkey
and comparatively evaluate the results obtained by
agglutination-based and ELISA techniques.

Materials and Methods
Bacterial strain: B. canis RM 6/66 strain (Culture
collection of Department of Microbiology, Faculty of
Veterinary Medicine, University of Ankara) was used as
antigen in TAT, 2ME-TAT and ELISA tests.
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Serum samples: A total of 362 serum samples
obtained from the temporarily kept dogs in 8 different
dog rehabilitation shelters in ‹stanbul and ‹zmir
provinces. The origins of dog serum samples are
presented in Table 1. All the dogs in shelters were
sampled once, and blood samples were brought to
laboratories obeying appropriate transport measures.
Once the sera were obtained they were separated in new
tubes. The serum samples in vacuum blood tubes were
separated by centrifugation at 1000 rpm for 10 minutes.
The sera were heat inactivated at 56 °C for 30 minutes
and kept at –20 °C until use.

Table 1. The origin and number of dog serum samples obtained.
Origin

Number of samples obtained

‹stanbul-1

59

‹stanbul-2

47

‹stanbul-3

38

‹stanbul-4

59

‹stanbul-5

57

‹zmir-1

80

‹Zmir-2

16

‹zmir-3

6

Total

362

Preparation
of
hyperimmune
serum:
Hyperimmune serum was prepared in 2 sero-negative
dogs after intravenous inoculation of 3 ml of formalininactivated B. canis antigen (3.7 x 108 bacteria/ml) that
was given three times with weekly intervals.
Hyperimmune sera were obtained from dogs 2 weeks
post-inoculation. Serum samples obtained from 8 healthy
sero-negative dogs were used as negative control serum.
Tube agglutination (TAT) and 2ME-TAT: The tube
agglutination antigen used in this test was prepared
according to method reported by Alton et al. (15).
Following the first culture, B. canis RM 6/66 strain was
subcultured onto 20 solid media (peptone 10 g, NaCl 5 g,
agar 20 g, distilled water 1000 ml) and incubated for 24
hours at 37 °C. At the end of the incubation period, all
colonies were collected with 10 ml of formalinized
(0.06%) Sorensen’s phosphate buffered saline. Having
filtered through several layers of sterile gauze the
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inoculum was inactivated by heating to 70 °C for one
hour. After the inoculum cooled, it was centrifuged at
10,000 rpm for 30 min. The supernatant was discarded
and the pellet was suspended with formalinized (0.5%)
Sorenson’s buffered saline and this suspension in
graduated centrifuge tubes was re-centrifuged for 30
min at 10,000 rpm. Antigen was standardized to have a
4.5% cell concentration and its OD value was determined
(OD=110; 490 nm) in a spectrophotometer (Photovolt
Model 401). Briefly, serum samples were diluted by
1/12.5 and then twofold serial dilutions were made up to
1/1600 from this dilution to obtain a final volume of 1 ml
in test tubes. One ml of tube agglutination antigens was
added to all tubes and the tubes were incubated at 37 °C
for 48 hours. After that, they were evaluated and 1/200
and higher dilutions showing ++ reactions were
determined as positive. 2ME-TAT was performed by
adding 0.6% formalin and 0.1 M 2-mercapthoethanol
(Merck) to serum dilution buffer in TAT test. All the steps
and evaluations were done as in TAT. Titers of positive
serum samples were determined as 1:400 in tube
agglutination test. The average titer of negative controls
was ≤ 1:25.

0.05 M carbonate buffer (pH 9.6) and added to
microplates in a volume of 100 µl for each well.
Microplates were incubated at 4 °C overnight. After the
incubation, plates were washed with 0.1 M PBS-Tween20 solution (0.05%, pH 7.2) three times. Serum samples
were diluted up to 1:200 with PBS-Tween-20 containing
1% bovine serum albumin (BSA) and 100 µl of this
dilution was added to each well. Following serum
addition, all plates were incubated at 37 °C for 1 hour.
All test serum samples were repeated three times. Plates
were washed as previously explained and 100 µl of
optimal conjugate dilution (1/8000) prepared in PBS
containing Tween-20 was added to each well. Microplates
were incubated for 1 hour at 37 °C and following the
washing step 50 µl of substrate solution [0.04% H2O2
(30%)+ o-phenylendiamine] was added to each well.
Microplates were left in darkness for 30 min and the
reaction was stopped with 2.5 N HCl. Optical densities
(ODs) of serum samples were determined at 490 nm in
an ELISA reader (Titertek Multiscan Plus) and at least 3
units higher than standard deviation of average OD of
negative controls were determined to be positive.

ELISA: B. canis RM 6/66 strain was propagated on
Brucella agar and after being subcultured on 20 petri
dishes containing Brucella agar, incubated at 37 °C for 24
hours. Growing colonies were collected from petri dishes
with Phosphate Buffered Saline (PBS) containing 0.6%
formalin. The collected cultures were pooled
(approximately 100 ml) in an Erlenmeyer flask and then
incubated at 60 °C for 30 minutes. The suspension was
centrifuged for 10 min at 10,000 rpm in a centrifuge
tube and this step was repeated three times with PBS.
The precipitate was sonicated for 15 min and then
centrifuged for 15 min at 10,000 rpm. The supernatant
was collected and dialyzed against distilled water at 4 °C
for 48 hours and used as ELISA antigen after this final
step. ELISA was performed in high affinity microplates as
reported by Mateu-de-Antoni et al. (16). For the
determination of optimal antigen and the anti-dog
peroxidase conjugate (A-6792; Sigma) the checkerboard
method was used. While antigen was diluted twofold
starting at 1/5 and up to 1/80 concentrations, the
conjugate was diluted twofold from 1/500 to 1/16,000.
The optimal dilutions of antigen and conjugate used in
ELISA were determined as 1/10 and 1/8000,
respectively. Optimal antigen dilution (1/10) was made in

Results
Of the 362 serum samples tested, 46 (12.7%), 28
(7.73%) and 27 (7.45%) were found to be positive for
B. canis by TAT, 2ME-TAT and ELISA, respectively (Table
2). Six (75%) out of the 8 dog kennels examined were
found to be positive for B. canis. Prevalence of
seropositive dogs was 5.26%-31.57%, 5 %-17.54%,
and 2.12%-15.78% by TAT, 2ME-TAT and ELISA,
respectively. The average seroprevalences were 12.7%,
7.73%, 7.45%, respectively. Positive serum antibody
titers were between 1:200 and 1:800 in TAT, while they
were between 1:200 and 1:400 in ME-TAT. Eighteen
(39.1%) and 19 (41.3%) out of 46 sera evaluated as
positive by TAT were found to be negative by 2ME-TAT
and ELISA, respectively. A 96.42% similarity was found
between 2 ME-TAT and ELISA test results.

Discussion
Diagnosis of brucellosis in dogs is based on clinical
findings, serological tests and bacteriological isolation.
Due to possible false-positive results that may be obtained
in serological tests, blood cultures should be attempted to
confirm the diagnosis. On the other hand, serological
781
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Table 2. Results obtained from TAT, ME-TAT and ELISA tests.
Serum origin

TAT

‹st 1 n = 59

11 (18.64)

7 (11.86)

6 (10.16)

‹st 2 n = 47

4 (8.51)

2 (4.25)

2 (2.12)

‹st 3 n = 38

2 (5.26)

2 (5.26)

2 (5.26)

‹st 4 n = 59

5 (8.47)

3 (5.08)

3 (5.08)

‹st 5 n = 57

18 (31.57)

10 (17.54)

‹zmir 1 n = 80

5 (6.25)

4 (5)

4 (5)

‹zmir 2 n = 16

0

0

0

‹zmir 3 n = 6

0

0

0

Total n = 362

46 (12.7)

28 (7.73)

27 (7.45)

tests are relatively easy to perform and provide a practical
advantage in determining the prevalence of infection. This
study’s purpose was the determination and comparative
evaluation of seroprevalence of Brucella canis infection
with serum samples obtained from different dog shelters
by agglutination tests and ELISA techniques.
The results indicated that the seroprevalence of B.
canis antibodies in samples was between 5.26% and
31.57%, 5% and 17.54%, and 2.12 % and 15.78% by
TAT, 2ME-TAT and ELISA, respectively. The average
seroprevalences were 12.7%, 7.73% and 7.45% with
the tests mentioned above, respectively. Eighteen
(39.1%) and 19 (41.3%) out of 46 sera evaluated as
positive by TAT were found to be negative by 2ME-TAT
and ELISA, respectively. A 96.42% similarity was found
between 2ME-TAT and ELISA results. These findings
showed that false-positive results obtained with TAT
were eliminated with 2ME-TAT and ELISA and the
difference between the former and the latter two tests
may have occurred because only B. canis specific IgGs
were detected with 2ME-TAT and ELISA. Dogs can be
declared negative when the agglutination tests are
negative, especially with the rapid serum agglutination
test (RSAT). However, only about 40-50% of the dogs
whose sera were positive in agglutination tests are
actually positive for canine brucellosis (2). Besides, 2mercaptoethanol treatments in agglutination tests have
been demonstrated to lower the false positive results by
50% (2,6,7). In this study, positive results obtained with
TAT were lowered 40% with ME-TAT and these findings
were confirmed with ELISA. The results obtained with
this study are consistent with the previous studies. Baldi
782

ME-TAT

ELISA

9 (15.78)

et al. (12) prepared and used two antigens, 18 kDa
cytoplasmic protein and cytoplasmic protein lacked LPS,
respectively, in two different ELISA procedures for the
diagnosis of canine brucellosis. They compared results
with the ELISA methods and found a 93.3% correlation
between ELISA and 2ME-TAT results. They also found
that capture ELISA using 18 kDa cytoplasmic protein as
an antigen could be more useful than indirect ELISA for
diagnosis. There is a correspondence between the
findings of this study and those carried out by Baldi et al.
(12).
In this study, amongst the 362 serum samples, 46
(12.7%), 28 (7.73%) and 27 (7.45%) were found to be
positive by TAT, 2ME-TAT and ELISA, respectively. Two
(75%) out of the 8 dog kennels examined were found to
be negative for B. canis. Negative results obtained in the
two shelters may be explained by the low number of dogs
kept in the kennels. B. canis seroprevalence is reported to
range between 2% and 30% in different countries (1-4).
There are few studies performed on this subject in
Turkey. Diker et al. (6) and ‹stanbulluo¤lu and Diker (7)
reported seroprevalence rates of 6.3% and 6.7% in 222
and 134 serum samples obtained from military, stray,
and household dogs by the use of 2ME-TAT, respectively.
The 2ME-TAT findings of this study (7.73%) are similar
to those reported in previous studies (3,6,7). However,
seropositiveness between shelters varies between 0% and
17.54%. Findings obtained from these studies show that
there has been no serious increase in B. canis
seroprevalence in last 20 years, but the infection still
exists.
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In conclusion, in this study it was observed that in
order to eliminate false-positive results obtained in
serological diagnosis of B. canis infections in dogs, tube
agglutination test should be combined at least with one
additional test such as 2ME-TAT or ELISA. A consistency
between the results of 2ME-TAT and ELISA was also
noted in the current study, which indicates that these

tests are good supplementary and/or alternative tests for
the serological diagnosis of B. canis infections. Since B.
canis antibodies were detected in sera obtained from dogs
in most of the dog shelters, it is concluded that protective
measures should be implemented to eliminate B. canis
infections in dogs and their residences.
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